Source: Google News – Health
Researchers have developed a long-acting weekly injection that delivers steady doses of levodopa and carbidopa, potentially transforming care for Parkinson’s disease. The biodegradable injectable maintains consistent drug levels, reducing the need for multiple daily pills and improving patient adherence. In lab tests, the gel released over 90% of the levodopa and 81% of the carbidopa within seven days, with minimal toxicity and easy…
